Blonder Tongue Laboratories Inc (BDRLQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,122 | -3,122 | -6,802 | 1,217 | 3,576 |
| Depreciation Amortization | 1,731 | 1,883 | 1,819 | 2,812 | 3,001 |
| Income taxes - deferred | 2,826 | 373 | 130 | 4 | -570 |
| Accounts receivable | 1,882 | 671 | 1,640 | -1,746 | 2,103 |
| Other Working Capital | 942 | 4,462 | -1,456 | -1,169 | -703 |
| Other Operating Activity | -344 | 1,419 | 5,926 | 2,593 | -1,151 |
| Operating Cash Flow | $3,915 | $5,686 | $1,257 | $3,711 | $6,256 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -639 | -1,137 | -2,575 | -803 | -368 |
| Purchase Of Investment | N/A | -1,167 | N/A | N/A | N/A |
| Purchase Sale Intangibles | 132 | N/A | N/A | N/A | -501 |
| Other Investing Activity | 975 | 635 | 0 | 0 | -501 |
| Investing Cash Flow | $336 | $-1,669 | $-2,575 | $-803 | $-869 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,117 | -922 |
| Debt Issued | 15,155 | 10,496 | 35,624 | N/A | N/A |
| Debt Repayment | -19,588 | -14,460 | -34,909 | -4,356 | -4,423 |
| Common Stock Issued | 57 | N/A | 2 | N/A | 273 |
| Common Stock Repurchased | N/A | -116 | -83 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -90 | 0 |
| Financing Cash Flow | $-4,376 | $-4,080 | $634 | $-2,329 | $-5,072 |
| Beginning Cash Position | 195 | 258 | 942 | 363 | 48 |
| End Cash Position | 70 | 195 | 258 | 942 | 363 |
| Net Cash Flow | $-125 | $-63 | $-684 | $579 | $315 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,915 | 5,686 | 1,257 | 3,711 | 6,256 |
| Capital Expenditure | -639 | -1,137 | -2,575 | -803 | -368 |
| Free Cash Flow | 3,276 | 4,549 | -1,318 | 2,908 | 5,888 |